Correlation Between Constellation Brands and Tscan Therapeutics
Can any of the company-specific risk be diversified away by investing in both Constellation Brands and Tscan Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Constellation Brands and Tscan Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Constellation Brands Class and Tscan Therapeutics, you can compare the effects of market volatilities on Constellation Brands and Tscan Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Constellation Brands with a short position of Tscan Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Constellation Brands and Tscan Therapeutics.
Diversification Opportunities for Constellation Brands and Tscan Therapeutics
0.78 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Constellation and Tscan is 0.78. Overlapping area represents the amount of risk that can be diversified away by holding Constellation Brands Class and Tscan Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Tscan Therapeutics and Constellation Brands is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Constellation Brands Class are associated (or correlated) with Tscan Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Tscan Therapeutics has no effect on the direction of Constellation Brands i.e., Constellation Brands and Tscan Therapeutics go up and down completely randomly.
Pair Corralation between Constellation Brands and Tscan Therapeutics
Considering the 90-day investment horizon Constellation Brands Class is expected to generate 0.52 times more return on investment than Tscan Therapeutics. However, Constellation Brands Class is 1.93 times less risky than Tscan Therapeutics. It trades about -0.35 of its potential returns per unit of risk. Tscan Therapeutics is currently generating about -0.23 per unit of risk. If you would invest 18,322 in Constellation Brands Class on November 18, 2024 and sell it today you would lose (2,028) from holding Constellation Brands Class or give up 11.07% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Constellation Brands Class vs. Tscan Therapeutics
Performance |
| Timeline |
| Constellation Brands |
| Tscan Therapeutics |
Constellation Brands and Tscan Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Constellation Brands and Tscan Therapeutics
The main advantage of trading using opposite Constellation Brands and Tscan Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Constellation Brands position performs unexpectedly, Tscan Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Tscan Therapeutics will offset losses from the drop in Tscan Therapeutics' long position.| Constellation Brands vs. Brown Forman | Constellation Brands vs. MGP Ingredients | Constellation Brands vs. Brown Forman | Constellation Brands vs. Diageo PLC ADR |
| Tscan Therapeutics vs. Apellis Pharmaceuticals | Tscan Therapeutics vs. Iteos Therapeutics | Tscan Therapeutics vs. Day One Biopharmaceuticals | Tscan Therapeutics vs. Acumen Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine |